Vitalhub (TSE:VHI) Given New C$14.00 Price Target at TD Securities

Vitalhub (TSE:VHI) had its price objective upped by TD Securities from C$13.00 to C$14.00 in a report published on Monday,BayStreet.CA reports. They currently have a buy rating on the stock.

Other analysts also recently issued reports about the company. Scotiabank set a C$14.00 price objective on Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, January 30th. Canaccord Genuity Group lifted their price objective on Vitalhub from C$12.00 to C$12.50 and gave the stock a “buy” rating in a research note on Thursday, January 16th. Finally, Raymond James set a C$13.50 price objective on Vitalhub and gave the stock an “outperform” rating in a research report on Thursday, March 27th. Five equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, Vitalhub has a consensus rating of “Buy” and an average price target of C$12.08.

Vitalhub Price Performance

Vitalhub stock opened at C$10.15 on Monday. The firm has a market cap of C$549.04 million, a PE ratio of 165.09, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. The stock’s fifty day moving average price is C$10.46 and its two-hundred day moving average price is C$10.36. Vitalhub has a one year low of C$5.80 and a one year high of C$12.09.

About Vitalhub

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.